All Type of News
Stricter measures urged on irregular drug bidding in hospitals
There is mounting voices that the government should step up efforts to crack down on the ceaseless low-priced drug tenders biddings in hospital markets.
Such irregular deals have produced negative side effects that...
Daiichi-Sankyo’s new combination form approved by KFDA
Daiichi-Sankyo Korea said Sunday it has received approval from the Korea Food and Drug Administration to market Servicar HCT, a new combination treatments containing three drugs.
Sevikar HCT is a single pill, fixed...
Galderma Korea releases Restylane Vital
Galderma Korea said it has recently launched Restylane Vital™ containing an anesthetic lidocaine, which has been marketed over 40 countries for its indication to restore skin hydrobalance and improve skin structure an...
Drug output growth slows in 2011
Korea's pharmaceutical output grew at a slower pace last year due to the government-mandated re-classification of 48 over-the-counter (OTC) drugs into quasi-drugs and slump in vaccine production, a government report s...
18 IMDs approved in 3 years
The Korea Food and Drug Administration said that a total of 18 incrementally modified drugs (IMDs) were approved over the past three years.
By company, Hanmi Pharmaceutical led any others with five products, follow...
Korea emerging as global drug trial hub
Korea is rapidly emerging as a global hub of clinical trials for multinational pharmaceutical companies thanks to its excellent infrastructure for clinical research.
In a recent interview with Yakup Shinmoon, Prof....
Doctors protest against medical policies
Two hundreds of doctors clad in plastic raincoats staged a rally in front of Seoul Station Plaza yesterday afternoon to protest against medical policies.
Despite the drizzling rain, members of the Korean Medical As...
Lipitor tablets getting smaller
Pfizer Korea announced Thursday that the Korea Food and Drug Administration has approved smaller sizes of Lipitor (atorvastatin) 10 mg, 20 mg, 40 mg and 80 mg, which will be available from next year.
Therefore, sma...
Largest sharehoders’ stocks worth over 100 billion won
The shareholdings of Ilyang Pharmaceutical Chairman Chung Do-un and Hanmi Pharmaceutical Chairman Lim-Sung ki are said to surpass 100 billion won, a pharmaceutical information provider said.
“The two chairmen’s sto...
Government urged to back innovative pharmaceutical firms
The government-selected innovative pharmaceutical firms have called for the government to provide more positive support to develop and promote new drugs, claiming the gap between the interests of policymakers and the ...
